3.4 Biosynthesis of Nucleotides
Nucleotides play a key role as the precursors of DNA and RNA, as activated intermediates in many biosyn-
thetic processes and as metabolic regulators. One particular nucleotide, adenosine 5-triphosphate (ATP),
is an important energy source. For example, an average human turns over 40 kg of ATP per day and can require
0.5 kg min^1 during exercise. The biosynthesis of nucleotides involves both constructive (anabolic) and
destructive (catabolic) pathways. In the following sections, we will concentrate on only the general prin-
ciples of nucleotide and nucleic acid metabolism and then show how certain steps are prime targets for
biosynthetic interference, especially for the design of anti-cancer and anti-viral agents.
3.4.1 Biosynthesis of Purine Nucleotides120,121
3.4.1.1 De novo Pathways. The key intermediate in the biosynthesis of both pyrimidines and purines
is -D-5-phosphoribosyl 1-pyrophosphate (PRPP), which is formed from -D-5-ribose 5-phosphate by a
116 Chapter 3
O
O
HO OH
P Ade
O
O
Y O
HO OH
O Ade
HO OH
Ade P O
O
O
Y
P
X
P
O
OOO O
P
O
OY
(i), (ii)
Figure 3.69 Syntheses of Ap 4 A and some analogues. Reagents: (i) (PhO) 2 POCl, pyridine; and (ii) O 3 PXPO 34
(XO, CH 2 , CF 2 , NH etc.; YO or S)
O
O
O O
N
NH
N
N
O
P
O
X
O
O P
O
S
Me
NH 2
H OMe
OMe
(i), (ii)
+pAUG m
(^7) G(5'-)pppAUG
Figure 3.70 Synthesis of the ‘cap’ structure of mRNA. Reagents: (i) Ag, imidazole, DMF; and (ii) H 3 O
P O Ado
S
O
O
P
OO
O P O Ado
S
O
Ø
P
OO
O
P
O
O
P O
O
O
O P O Ado
S
Ø
O
P O Ado
S
O
Ø
Sp Rp
Sp
(i)
(ii)
(iii)
Figure 3.68 Syntheses of (Rp)-[a^17 O] ATP and (Sp) AMP. Reagents: (i) Br 2 , H 217 O; (ii) snake venom phosphodi-
esterase, H 218 O (retention); and (iii) pyruvate kinase, Mg^2 , K, phosphoenol pyruvate
http://www.ebook3000.com